Logo

BioCat to Distribute Kreatech s Labeling Tech in Germany, Switzerland, Austria

Sep 14, 2005

NEW YORK, Sept. 14 (GenomeWeb News) - Kreatech Biotechnology has signed up BioCat to distribute its molecular labeling technology in Germany, Switzerland, and Austria, the Amsterdam-based company said today.

 

Under the agreement, BioCat, located in Heidelberg, Germany, will supply Kreatech's Universal Linkage System, which allows users to attach a variety of labels to DNA, RNA, or proteins, to laboratories in Germany, Switzerland, and Austria.

 

Kreatech said it expects to expand its distribution network further in the next few month, both in Europe and Asia.

Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.